Low risk prostate cancer: active surveillance does not increase unfavourable outcomes, study finds

Active surveillance of men with prostate cancer with a low risk of metastasis is an appropriate alternative to immediate surgery or radiation, a long term, prospective, multicentre study of 2155 men has found.1

The Canary Prostate Active Surveillance (Pass) study was conducted at 10 North American medical centres, with findings reported in JAMA. It found that 10 years after diagnosis disease had not progressed in almost half (49%) of the men. Fewer than 2% of the men developed metastatic disease, and fewer than 1% died from prostate cancer.

“The rates of unfavorable outcomes—including adverse pathology at surgical procedure, recurrence after treatment, or metastasis—do not …